跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 196 条关于
“Semaphorin 4D”
全部
196
临床试验
127
药物
16
机构
3
资讯
50
去年
Vaccinex's Pepinemab Shows Promise in Alzheimer's Disease Trial
8个月前
Vaccinex Secures $60 Million to Advance Phase 2b Trial of Alzheimer's Drug Pepinemab
2个月前
Vaccinex to Present New Biomarker Data Supporting Expanded Phase 2b Trial of Pepinemab in Early Alzheimer's Disease
去年
Vaccinex's Pepinemab Shows Promise in Turning "Cold" Tumors "Hot" Through Enhanced Immune Response
去年
4DMT Prioritizes 4D-150 and 4D-710, Extends Cash Runway into 2028
去年
4D-150 Gene Therapy Shows Promising Results in Diabetic Macular Edema Trial
2年前
FDA Lifts Clinical Hold on 4D Molecular Therapeutics' Fabry Disease Gene Therapy Trial
去年
4D Path's Digital Biomarker Identifies Treatment Responders in Previously Resistant Breast Cancer Patients
去年
Aeva Secures $50 Million Strategic Investment for 4D LiDAR Technology Expansion
去年
4D Molecular Therapeutics Shifts Focus to Late-Stage Gene Therapy for Eye Disease
第 1 页,共 5 页
上一页
下一页